Skip to Main Content

Paper Details

Synergism of FAK and tyrosine kinase inhibition in Ph<sup>+</sup> B-ALL.
JCI Insight
37
2016
-, ABL1, B, B-ALL, BCR, BCR-ABL1+ B progenitor, FAK, FAK1, IKZF1, IKZF1-altered cells, Ikaros, Ph, Ph+, Ph+ B-ALL, VS-4718, bone marrow stem cell, leukemic, leukemic cell, lymphoid transcription factor Ikaros, stem cell, tyrosine, tyrosine kinase
Author NameAffiliation
Kathryn EvansChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales
Jonathan A PachterVerastem Inc.
Peter J HoughtonGreehey Children's Cancer Research Institute, University of Texas Health Science Center San Antonio
Malcolm A SmithNational Cancer Institute
Malcolm A SmithNational Cancer Institute
Richard B LockChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales
Charles G MullighanSt. Jude Children's Research Hospital
  • 1 - 7

Datasets

Release 1.2